Sujets

Sur cette page, les lecteurs peuvent obtenir une liste de documents classifiés par thèmes. Cliquez sur le nom du thème pour voir affichées les sous-thèmes ou pour revenir aux thèmes principaux. Cliquez sur l'icône d'un sous-thème pour obtenir la liste des documents qui s'y rapportent. Les publications sont disponibles en HTML, PDF , DOC ou XLS format. Veuillez cliquer sur l'icône correspondante pour accéder à la publication. La publication est disponible uniquement en format PDF lorsque l'icône PDF est située sur la page de couverture de la publication. Si l'icône PDF est située près du titre de la publication, les formats HTML et PDF sont disponibles.
Étendre le menu Sous-collections.
364 documents en 1 page
 
 
 
 
Ouvrir ce document et afficher son contenu

2015 Global Survey on Health Technology Assessment by National Authorities. Main Findings

An:

2015;

Pages:

40;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book

An:

2015;

Pages:

32;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book

An:

2015;

Pages:

44;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015

An:

2015;

Pages:

30;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Access to Cancer Treatment: A Study of Medicine Pricing Issues with Recommendations for Improving Access to Cancer Medication

An:

2015;

Pages:

54;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Advance Price or Purchase Commitments to Create Markets for Treatments for Diseases of Poverty: Lessons from Three Policies

An:

2005;

Pages:

7;


Régions:

 
Ouvrir ce document et afficher son contenu

Assessment of the Medicines Benefit Program of the Ghana National Health Insurance Scheme. December 2015

An:

2015;

Pages:

44;


Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Better Life Through Medicine—let’s Leave No One Behind. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

2;

Régions:

 
Ouvrir ce document et afficher son contenu

Consultation on Financing of Essential Medicines. Manila, Philippines, 4-6 October 2006

An:

2007;

Pages:

58;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Cost Savings of Switching Private Sector Consumption from Originator Brand Medicines to Generic Equivalents. World Health Report (2010) - Background Paper, 35

An:

2010;

Pages:

11;


Régions:

 
Ouvrir ce document et afficher son contenu

Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015

An:

2015;

Pages:

31;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Ensuring that Essential Medicines are also Affordable Medicines: Challenges and Options. Discussion Paper UNITAID

An:

2016;

Pages:

52;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Essential Medicines for Universal Health Coverage. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

2;

Régions:

 
Ouvrir ce document et afficher son contenu

Essential Medicines for Universal Health Coverage. (The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

74;


Régions:

 
Ouvrir ce document et afficher son contenu

Ethiopia National Health Insurance Scale-Up Assessment on Medicines Financing, Use, and Benefit Management: Findings, Implications, and Recommendations. August 2016

An:

2016;

Pages:

78;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Financement de la recherche-développement. Rapport du Groupe de travail d’experts [Arabic] [Chinese] [English] [Russian] [Spanish]

An:

2010;

Pages:

104;


Régions:

 
Ouvrir ce document et afficher son contenu

Financiación de la Investigación y el Desarrollo. Informe del Grupo de Expertos [Arabic] [Chinese] [English] [French] [Russian]

An:

2010;

Pages:

106;


Régions:

 
Ouvrir ce document et afficher son contenu

Financing of R&D Preparedness and Response to Epidemic Emergencies. Outcome document. October 29-30, 2015 Oslo, Norway

An:

2015;

Pages:

6;


Régions:

 
Ouvrir ce document et afficher son contenu

First Meeting on Access to Medicines under Universal Health Coverage in the Asia Pacific Region. 18–19 September 2014, Seoul, Republic of Korea

An:

2014;

Pages:

126;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Fourth Meeting on Access to Medicines Under Universal Health Coverage in the Asia Pacific Region. 26–27 September 2017, Seoul, Republic of Korea

An:

2017;

Pages:

90;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

The Global Drug Facility as an intervention in the market for tuberculosis drugs (Bull World Health Organ 2015;93:237–248A)

An:

2015;

Pages:

13;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals

An:

2015;

Pages:

216;


Régions:

 
Ouvrir ce document et afficher son contenu

Health Technology Assessment and Health Policy-making in Europe. Current Status, Challenges and Potential. Observatory Studies Series No 14

An:

2008;

Pages:

197;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Identification of Bottlenecks Affecting Consolidated Purchases of Antimalarials through the Strategic Fund [Spanish]

An:

2013;

Pages:

31;


 
Ouvrir ce document et afficher son contenu

Implementation tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-resource Settings

An:

2013;

Pages:

210;


Régions:

 
Ouvrir ce document et afficher son contenu

Innovative payment models for high-cost innovative medicines. Report of the Expert Panel on effective ways of investing in Health (EXPH)

An:

2018;

Pages:

81;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

An:

2016;

Pages:

13;

Régions:

 
Ouvrir ce document et afficher son contenu

Low-value Health Care with High Stakes: Promoting the Rational Use of Antimicrobials. (Part I, chapter 3, pages 115-158 of Tackling Wasteful Spending on Health)

An:

2017;

Pages:

1;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)

An:

2012;

Pages:

1088;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Medicines in Health Systems: Advancing Access, Affordability and Appropriate Use

An:

2014;

Pages:

117;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Medicines Reimbursement Policies in Europe (2018)

An:

2018;

Pages:

200;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Methods to Analyse Medicine Utilization and Expenditure to Support Pharmaceutical Policy Implementation. Geneva: World Health Organization

An:

2018;

Pages:

54;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Negotiating Prices of Drugs for Rare Diseases. (Bull World Health Organ 2016;94:779–781)

An:

2016;

Pages:

3;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-resource Settings

An:

2010;

Pages:

66;


Régions:

 
Ouvrir ce document et afficher son contenu

Pharmacare 2020 : L’avenir de l’assurance‑médicaments au Canada. 15 juillet 2015 [English]

An:

2015;

Pages:

23;


Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Pharmacare 2020: The Future of Drug Coverage in Canada. 15 July 2015 [French]

An:

2015;

Pages:

23;


Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Pharmaceutical Pricing and Reimbursement Reform in Kyrgyzstan (2016) [Russian]

An:

2016;

Pages:

84;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Pharmaceutical Regulation in 15 European Countries: Review. Health Systems in Transition, 2016; 18(5):1–118

An:

2016;

Pages:

143;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

The Pharmaceutical System of the Netherlands. A Comparative Analysis Between the Dutch Out-patient Pharmaceutical System, in Particular the Pricing and Reimbursement Characteristics, and Those of the Other European Union Member States, with a Special Focus on Tendering-like Systems.

An:

2010;

Pages:

74;

Documents similaires:

 
Ouvrir ce document et afficher son contenu

Prescription Drugs: Innovation, Spending, and Patient Access. December 7, 2016. Report to Congress

An:

2016;

Pages:

147;


 
Ouvrir ce document et afficher son contenu

Pricing and Reimbursement Reform in Kyrgyzstan (2016) Russian version Реформа ценообразования и возмещения стоимости лекарственных средств в КыргызстанеPharmaceutical [English]

An:

2016;

Pages:

84;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Promising Practices: 5 - Service Delivery and Utilization. Brief #5 in the Promising Practices in Supply Chain Management Series

An:

2014;

Pages:

19;


Régions:

 
Ouvrir ce document et afficher son contenu

An R&D Blueprint for Action to Prevent Epidemics. Funding & Coordination Models for Preparedness and Response. May 2016 (Being ready for the next epidemic: How to improve R&D funding for preparedness and response to emerging pathogens. An exploration of different funding and coordination models in the framework of the WHO R&D Blueprint for action to prevent epidemics)

An:

2016;

Pages:

34;


Régions:

 
Ouvrir ce document et afficher son contenu

Reducing Ineffective Health Care Spending on Pharmaceuticals. (Part II, chapter 4, pages 161-191 of Tackling Wasteful Spending on Health)

An:

2017;

Pages:

1;


Régions:

 
Ouvrir ce document et afficher son contenu

Reducing the Price of Treatment for Multidrug-resistant Tuberculosis Through the Global Drug Facility (Bull World Health Organ 2015;93:279–282)

An:

2015;

Pages:

4;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Research and Development Coordination and Financing. Report of the Expert Working Group [Arabic] [Chinese] [French] [Russian] [Spanish]

An:

2010;

Pages:

98;


Régions:

 
Ouvrir ce document et afficher son contenu

Research and Development Coordination and Financing. Report of the Expert Working Group (Arabic version) تقرير فريق الخبراء العامل التابع لمنظمة الصحة العالمية والمعني بتمويل أنشطة البحث والتطوير [Chinese] [English] [French] [Russian] [Spanish]

An:

2010;

Pages:

108;


Régions:

 
Ouvrir ce document et afficher son contenu

Research and Development Coordination and Financing. Report of the Expert Working Group (Chinese version) 世界卫生组织研究与开发筹资问题 专家工作小组报告 [Arabic] [English] [French] [Russian] [Spanish]

An:

2010;

Pages:

98;


Régions:

 
Ouvrir ce document et afficher son contenu

Research and Development Coordination and Financing. Report of the Expert Working Group (Russian version) [Arabic] [Chinese] [English] [French] [Spanish]

An:

2010;

Pages:

112;


Régions: